Fieldpoint Private Securities LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,826 shares of the company’s stock, valued at approximately $497,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Jacobi Capital Management LLC boosted its position in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Krilogy Financial LLC raised its stake in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares during the last quarter. Captrust Financial Advisors acquired a new position in Colgate-Palmolive in the 2nd quarter valued at about $122,000. AlphaMark Advisors LLC raised its stake in Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the last quarter. Finally, Bruderman Asset Management LLC acquired a new position in Colgate-Palmolive in the 2nd quarter valued at about $126,000. 72.85% of the stock is currently owned by institutional investors and hedge funds.
Shares of Colgate-Palmolive (NYSE CL) traded up $0.43 during trading on Monday, reaching $70.19. The company had a trading volume of 3,455,658 shares, compared to its average volume of 4,330,000. Colgate-Palmolive has a 1 year low of $66.47 and a 1 year high of $77.91. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. The stock has a market cap of $61,630.00, a P/E ratio of 30.79, a P/E/G ratio of 2.58 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.75. The company had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period last year, the business earned $0.75 EPS. research analysts forecast that Colgate-Palmolive will post 3.18 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is 70.18%.
In other news, COO Noel R. Wallace sold 126,304 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total transaction of $9,318,709.12. Following the sale, the chief operating officer now owns 305,631 shares of the company’s stock, valued at approximately $22,549,455.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Henning I. Jakobsen sold 36,215 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $71.22, for a total value of $2,579,232.30. Following the sale, the vice president now directly owns 70,783 shares in the company, valued at approximately $5,041,165.26. The disclosure for this sale can be found here. In the last three months, insiders have sold 327,451 shares of company stock worth $23,534,707. 1.02% of the stock is currently owned by insiders.
Several research analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a report on Tuesday, December 19th. BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Finally, Citigroup upped their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Tuesday, January 30th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $77.71.
ILLEGAL ACTIVITY WARNING: “Fieldpoint Private Securities LLC Acquires Shares of 6,826 Colgate-Palmolive (CL)” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/12/fieldpoint-private-securities-llc-invests-497000-in-colgate-palmolive-cl-stock.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.